Adial Pharmaceuticals (ADIL) Surges on Plans to Expand Lead Asset AD04 into Opioid Addiction
Tweet Send to a Friend
Adial Pharmaceuticals (NASDAQ: ADIL) is gaining 37% in pre-open trade after the company announced plans to expand activities around ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
